Loading...
Becton, Dickinson and Company
BDX•NYSE
HealthcareMedical - Instruments & Supplies
$173.40
$2.37(1.39%)
Becton, Dickinson and Company (BDX) Financial Performance & Statements
Review Becton, Dickinson and Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.16%
↑ 4.16%
Operating Income Growth
13.55%
↑ 13.55%
Net Income Growth
14.89%
↑ 14.89%
Operating Cash Flow Growth
27.03%
↑ 27.03%
Operating Margin
11.33%
↑ 11.33%
Gross Margin
44.50%
↑ 44.50%
Net Profit Margin
7.18%
↑ 7.18%
ROE
5.86%
↑ 5.86%
ROIC
5.05%
↑ 5.05%
Becton, Dickinson and Company (BDX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Becton, Dickinson and Company stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.17B | $5.44B | $4.99B | $5.04B |
| Cost of Revenue | $2.93B | $2.95B | $2.68B | $2.74B |
| Gross Profit | $2.23B | $2.49B | $2.31B | $2.30B |
| Gross Profit Ratio | $0.43 | $0.46 | $0.46 | $0.46 |
| R&D Expenses | $343.00M | $302.00M | $299.00M | $299.00M |
| SG&A Expenses | $1.32B | $1.26B | $1.20B | $1.19B |
| Operating Expenses | $1.78B | $1.86B | $1.59B | $1.47B |
| Total Costs & Expenses | $4.71B | $4.62B | $4.28B | $4.21B |
| Interest Income | $23.00M | $55.00M | $48.00M | $26.00M |
| Interest Expense | $155.00M | $155.00M | $137.00M | $125.00M |
| Depreciation & Amortization | $607.00M | $47.00M | $568.00M | $571.00M |
| EBITDA | $1.07B | $697.00M | $1.21B | $1.33B |
| EBITDA Ratio | $0.21 | $0.13 | $0.24 | $0.26 |
| Operating Income | $453.00M | $650.00M | $715.00M | $835.00M |
| Operating Income Ratio | $0.09 | $0.12 | $0.14 | $0.17 |
| Other Income/Expenses (Net) | -$147.00M | -$136.00M | -$215.00M | -$101.00M |
| Income Before Tax | $306.00M | $514.00M | $500.00M | $633.00M |
| Income Before Tax Ratio | $0.06 | $0.09 | $0.10 | $0.13 |
| Income Tax Expense | $3.00M | $114.00M | $13.00M | $96.00M |
| Net Income | $303.00M | $400.00M | $487.00M | $537.00M |
| Net Income Ratio | $0.06 | $0.07 | $0.10 | $0.11 |
| EPS | $1.05 | -$4.51 | $1.68 | $1.85 |
| Diluted EPS | $1.04 | -$4.49 | $1.68 | $1.85 |
| Weighted Avg Shares Outstanding | $289.50M | $289.61M | $289.56M | $289.52M |
| Weighted Avg Shares Outstanding (Diluted) | $290.39M | $290.60M | $290.25M | $290.34M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan